{"id":11423,"date":"2021-09-08T12:56:47","date_gmt":"2021-09-08T10:56:47","guid":{"rendered":"https:\/\/h3africa.org\/?page_id=11423"},"modified":"2021-09-08T14:20:01","modified_gmt":"2021-09-08T12:20:01","slug":"h3africa-dbac-approvals","status":"publish","type":"page","link":"https:\/\/h3africa.org\/index.php\/h3africa-dbac-approvals\/","title":{"rendered":"H3Africa DBAC Approvals"},"content":{"rendered":"<p>[vc_row][vc_column][vc_column_text css=&#8221;.vc_custom_1631098962553{margin-top: 36px !important;}&#8221;]<\/p>\n<h3>DBAC Approvals<\/h3>\n<hr>\n<p>\n<table id=\"tablepress-24\" class=\"tablepress tablepress-id-24\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Name<\/th><th class=\"column-2\">Institution\/Research Group<\/th><th class=\"column-3\">Study<\/th><th class=\"column-4\">Datasets<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Prof JM Heckmann<\/td><td class=\"column-2\">University of Capetown, South Africa<\/td><td class=\"column-3\">Investigating the genetic basis of amyotrophic lateral sclerosis (ALS) and other neuromuscular disorders in South Africans<\/td><td class=\"column-4\">TrypanoGEN and H3ABaylor WGS datasets: <br \/>\nH3AChip-TrypanoGEN 2 EGAD00001004220<br \/>\nH3AChip-AWI-Gen  EGAD00001004448<br \/>\nH3AChip-TrypanoGEN 1  EGAD00001004393<br \/>\nH3AChip-ELSI  EGAD00001004316<br \/>\nH3AChip-CAfGEN EGAD00001004533<br \/>\nH3AChip-ACCME  EGAD00001004505<br \/>\nH3AChip-NEEDI  EGAD00001004334<br \/>\nH3AChip-MalSic  EGAD00001004557<br \/>\nTrypanoGEN Main  EGAD00001005076<br \/>\nAWI-Gen Phase 1 WGS data from 100 South Africans EGAD00001006418<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">Prof Carina Schlebusch<\/td><td class=\"column-2\">Uppsala University, Evolutionary Biology Centre, Sweden<\/td><td class=\"column-3\">A genomic perspective on the history of Africa<\/td><td class=\"column-4\">H3A-Baylor and TrypanoGEN WGS datasets: <br \/>\nH3AChip-TrypanoGEN 2  EGAD00001004220<br \/>\nH3AChip-AWI-Gen  EGAD00001004448<br \/>\nH3AChip-TrypanoGEN 1 EGAD00001004393<br \/>\nH3AChip-ELSI  EGAD00001004316<br \/>\nH3AChip-CAfGEN  EGAD00001004533<br \/>\nH3AChip-ACCME  EGAD00001004505<br \/>\nH3AChip-NEEDI  EGAD00001004334<br \/>\nH3AChip-MalSic  EGAD00001004557<br \/>\nTrypanoGEN Main  EGAD00001005076<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Prof Christof R. Hauck<\/td><td class=\"column-2\">Konstanz University, Germany<\/td><td class=\"column-3\">CEACAM polymorphisms and their role for bacterial adhesin binding<\/td><td class=\"column-4\">WES\/WGS:  <br \/>\nCAfGEN Exome  EGAD00001006224<br \/>\nTrypanoGEN Main  EGAD00001005076<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">Maria Chahrour, Ph.D.<\/td><td class=\"column-2\">University of Texas Southwestern Medical Center, <br \/>\nUnited States<\/td><td class=\"column-3\">The genetics of neurodevelopmental disorders<\/td><td class=\"column-4\">H3AChip data: <br \/>\nH3AChip-Trypanogen 2 EGAD00001004220; <br \/>\nH3AChip-Awi-gen  EGAD00001004448; <br \/>\nH3AChip-Elsi  EGAD00001004316; <br \/>\nH3AChip-Trypanogen 1  EGAD00001004393; <br \/>\nH3AChip-Cafgen  EGAD00001004533; <br \/>\nH3AChip-Accme  EGAD00001004505; <br \/>\nH3AChip-Needi  EGAD00001004334; <br \/>\nH3AChip-Malsic  EGAD00001004557.<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Alicia Martin, Ph.D<\/td><td class=\"column-2\">Broad Institute, Massachusetts, United States<\/td><td class=\"column-3\">Developing a population genetic and imputation resource of diverse human genomes<\/td><td class=\"column-4\">WGS datasets: <br \/>\nH3AChip-Phenotype EGAD00001005310;  <br \/>\nAWI-Gen Phase 1 GWAS Genotype EGAD00010001996; <br \/>\nAWI-Gen Phase 1 WGS data from 100 South Africans EGAD00001006418;  <br \/>\nH3AChip-Trypanogen 2 EGAD00001004220;  H3AChip-Awi-gen EGAD00001004448; <br \/>\nH3AChip-Elsi EGAD00001004316;  <br \/>\nH3AChip-Trypanogen 1 EGAD00001004393;  H3AChip-Cafgen EGAD00001004533;  <br \/>\nH3AChip-Accme EGAD00001004505; <br \/>\nH3AChip-Needi EGAD00001004334;  <br \/>\nH3AChip-Malsic EGAD00001004557<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">Dr Jana Vandrovcova<\/td><td class=\"column-2\">University College London, United Kingdom<\/td><td class=\"column-3\">The International Centre for Genomic Medicine in Neuromuscular Disease (ICGNMD)<\/td><td class=\"column-4\">WGS\/WES datasets: <br \/>\nAWI-Gen Phase 1 GWAS Genotype EGAD00010001996<br \/>\nAWI-Gen Phase 1 WGS data from 100 South Africans EGAD00001006418<br \/>\nH3AChip-Trypanogen 2 EGAD00001004220<br \/>\nH3AChip-Awi-gen EGAD00001004448<br \/>\nH3AChip-Elsi EGAD00001004316<br \/>\nH3AChip-Trypanogen 1 EGAD00001004393<br \/>\nH3AChip-Cafgen EGAD00001004533<br \/>\nH3AChip-Accme EGAD00001004505<br \/>\nH3AChip-Needi EGAD00001004334<br \/>\nNEEDI SNPs and INDELS EGAD00001006295<br \/>\nCAfGEN Exome EGAD00001006224<br \/>\nH3AChip-Malsic EGAD00001004557<br \/>\nTrypanoGEN Main EGAD00001005076<br \/>\nAWI-Gen Pilot EGAD00010001258<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">Prof Michael Pepper<\/td><td class=\"column-2\">University of Pretoria, South Africa<\/td><td class=\"column-3\">To determine the African variant allele frequencies and predicted variant effects of<br \/>\ngenes associated with neonatal encephalopathy with suspected hypoxic-ischemic encephalopathy<br \/>\n(NESHIE), Coronavirus disease 2019 (COVID-19), cystic fibrosis and cardiometabolic diseases<\/td><td class=\"column-4\">H3AChip-Trypanogen 2 EGAD00001004220<br \/>\nH3AChip-Awi-gen EGAD00001004448<br \/>\nH3AChip-Elsi EGAD00001004316<br \/>\nH3AChip-Trypanogen 1 EGAD00001004393<br \/>\nH3AChip-Cafgen EGAD00001004533<br \/>\nH3AChip-Accme EGAD00001004505<br \/>\nH3AChip-Needi EGAD00001004334<br \/>\nCAfGEN Exome EGAD00001006224<br \/>\nH3AChip-Malsic EGAD00001004557<br \/>\nTrypanoGEN Main EGAD00001005076<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">Dr Sandra Beleza<\/td><td class=\"column-2\">University of Leicester, United Kingdom<\/td><td class=\"column-3\">Whole Genome Sequencing of Populations from Cabinda, Angola and Maputo, Mozambique<\/td><td class=\"column-4\">H3AChip data<br \/>\nH3AChip-Trypanogen 2 EGAD00001004220<br \/>\nH3AChip-Elsi EGAD00001004316<br \/>\nH3AChip-Trypanogen 1 EGAD00001004393<br \/>\nH3AChip-Cafgen EGAD00001004533<br \/>\nH3AChip-Accme EGAD00001004505<br \/>\nH3AChip-Needi EGAD00001004334<br \/>\nH3AChip-Malsic EGAD00001004557<br \/>\nH3AChip-AWI-Gen EGAD00001004448<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">Prof Ezekiel Adebiyi<\/td><td class=\"column-2\">Covenant University Ota, Ogun State, Nigeria<\/td><td class=\"column-3\">Genome-wide characterization of complex variants and their phenotypic effects in African populations<\/td><td class=\"column-4\">WGS datasets: <br \/>\nH3AChip-Elsi EGAD00001004316<br \/>\nNEEDI SNPs and INDELS EGAD00001006295<br \/>\nH3AChip-Malsic EGAD00001004557<br \/>\nH3AChip-Trypanogen 1 EGAD00001004393<br \/>\nAWI-Gen Phase 1 GWAS Genotype EGAD00010001996<br \/>\nH3AChip-Needi EGAD00001004334<br \/>\nCAfGEN Exome EGAD00001006224<br \/>\nAWI-Gen Pilot EGAD00010001258<br \/>\nTrypanoGEN Main EGAD00001005076<br \/>\nH3AChip-Phenotype EGAD00001005310<br \/>\nH3AChip-Trypanogen 2 EGAD00001004220<br \/>\nH3AChip-Awi-gen EGAD00001004448<br \/>\nH3AChip-Cafgen EGAD00001004533<br \/>\nAWI-Gen Phase 1 Phenotype EGAD00001006425<br \/>\nAWI-Gen Phase 1 Pilot Microbiome PRJEB40733<br \/>\nAWI-Gen Phase 1 Pilot Microbiome Phenotype EGAD00001006581<br \/>\nAWI-Gen Phase 1 WGS data from 100 South Africans EGAD00001006418<br \/>\nH3Africa Consortium WGS VCF EGAD00001008577<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">Dr Carla Marquez-Luna<\/td><td class=\"column-2\">Martingale Labs, Brooklyn, United States<\/td><td class=\"column-3\">Evaluating the utility of current clinical genetic testing methods across diverse populations<\/td><td class=\"column-4\">WGS datasets: <br \/>\nH3Africa Consortium WGS VCF EGAD00001008577<\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\">Prof Michael Pepper<\/td><td class=\"column-2\">University of Pretoria, South Africa<\/td><td class=\"column-3\">A multi-variate, multi-omics study on the pathogenesis of moderate-severe neonatal encephalopathy with suspected hypoxic ischemic encephalopathy<\/td><td class=\"column-4\">Datasets: <br \/>\nH3AChip-Elsi EGAD00001004316<br \/>\nH3AChip-Malsic EGAD00001004557<br \/>\nH3AChip-Trypanogen 1 EGAD00001004393<br \/>\nH3AChip-Accme EGAD00001004505<br \/>\nH3AChip-Needi EGAD00001004334<br \/>\nCAfGEN Exome EGAD00001006224<br \/>\nH3AChip-Trypanogen 2 EGAD00001004220<br \/>\nH3AChip-Awi-gen EGAD00001004448<br \/>\nH3AChip-Cafgen EGAD00001004533<br \/>\nH3Africa Consortium WGS VCF EGAD00001008577<\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\">Dr Catherine Tcheandjieu<\/td><td class=\"column-2\">University of California San Francisco, California, USA<\/td><td class=\"column-3\">Understanding the 9p21.3 coronary artery disease-risk region<\/td><td class=\"column-4\">WGS, SNP array, and phenotype datasets:<br \/>\nAWI-Gen Phase 1 GWAS Genotype EGAD00010001996<br \/>\nAWI-Gen Phase 1 Phenotype EGAD00001006425<br \/>\nH3Africa Consortium WGS VCF EGAD00001008577<\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\">Dr Houcemeddine Othman<\/td><td class=\"column-2\">University of the Witwatersrand, Johannesburg, South Africa<\/td><td class=\"column-3\">An integrative data-driven approach to the genomics of anti-tuberculosis and anti-malarial drug responses in African populations: The AGORA-TM project<\/td><td class=\"column-4\">WGS datasets: <br \/>\nH3Africa Consortium WGS VCF EGAD00001008577<\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-1\">Dr Hongsheng Gui<\/td><td class=\"column-2\">Michigan State University Health Sciences, <br \/>\nUnited States<\/td><td class=\"column-3\">Pharmacoepidemiology and pharmacogenomics of opioid use and use disorder during COVID pandemic<\/td><td class=\"column-4\">WGS datasets: <br \/>\nH3Africa Consortium WGS VCF EGAD00001008577<\/td>\n<\/tr>\n<tr class=\"row-16\">\n\t<td class=\"column-1\">Etienne Patin, PhD<\/td><td class=\"column-2\">Institut Pasteur, France<\/td><td class=\"column-3\">The impact of recent demographic changes on the genetic architecture of complex diseases in Central Africans<\/td><td class=\"column-4\">WGS datasets:<br \/>\nH3AChip-Elsi EGAD00001004316<br \/>\nH3AChip-Malsic EGAD00001004557<br \/>\nH3AChip-Trypanogen 1 EGAD00001004393<br \/>\nH3AChip-Accme EGAD00001004505<br \/>\nH3AChip-Needi EGAD00001004334<br \/>\nH3AChip-Trypanogen 2 EGAD00001004220<br \/>\nH3AChip-Awi-gen EGAD00001004448<br \/>\nH3AChip-Cafgen EGAD00001004533<\/td>\n<\/tr>\n<tr class=\"row-17\">\n\t<td class=\"column-1\">Prof Vanessa Dumeaux<\/td><td class=\"column-2\">The University of Western Ontario, Canada<\/td><td class=\"column-3\">Functional Interactions and Global Diversity in Gut Microbiomes: Advancing Microbial Community Type Identification with Deep Learning Approaches<\/td><td class=\"column-4\">AWI-Gen Phase 1 Pilot Microbiome Phenotype EGAD00001006581<\/td>\n<\/tr>\n<tr class=\"row-18\">\n\t<td class=\"column-1\">Prof Yukinori Okada<\/td><td class=\"column-2\">Osaka University Graduate School of Medicine, Japan<\/td><td class=\"column-3\">Elucidation of disease pathology by multi-omics analysis of the homogeneity and heterogeneity of selection signatures in diverse populations<\/td><td class=\"column-4\">WGS datasets:<br \/>\nH3AChip-Elsi EGAD00001004316<br \/>\nH3AChip-Malsic EGAD00001004557<br \/>\nH3AChip-Trypanogen 1 EGAD00001004393<br \/>\nAWI-Gen Phase 1 GWAS Genotype EGAD00010001996<br \/>\nH3AChip-Accme EGAD00001004505<br \/>\nH3AChip-Needi EGAD00001004334<br \/>\nAWI-Gen Pilot EGAD00010001258<br \/>\nTrypanoGEN Main EGAD00001005076<br \/>\nACCME NIH H3Africa phs001945.v1.p1<br \/>\nH3AChip-Phenotype EGAD00001005310<br \/>\nH3AChip-Trypanogen 2 EGAD00001004220<br \/>\nH3AChip-Awi-gen EGAD00001004448<br \/>\nH3AChip-Cafgen EGAD00001004533<br \/>\nAWI-Gen Phase 1 Phenotype EGAD00001006425<br \/>\nReMAC-Phenotype EGAD00001006244<br \/>\nAWI-Gen Phase 1 WGS data from 100 South Africans EGAD00001006418<br \/>\nH3Africa Consortium WGS VCF EGAD00001008577<\/td>\n<\/tr>\n<tr class=\"row-19\">\n\t<td class=\"column-1\">Dr Mahmoud Aarabi<\/td><td class=\"column-2\">University of Pittsburgh, United States<\/td><td class=\"column-3\">Carrier frequency of autosomal recessive conditions in African population<\/td><td class=\"column-4\">WGS data<br \/>\nTrypanoGEN Main EGAD00001005076<\/td>\n<\/tr>\n<tr class=\"row-20\">\n\t<td class=\"column-1\">Prof David Curtis<\/td><td class=\"column-2\">University College London, United Kingdom<\/td><td class=\"column-3\">Distribution of genetic variants across human populations<\/td><td class=\"column-4\">AWI-Gen Phase 1 GWAS Genotype EGAD00010001996<br \/>\nH3Africa Consortium WGS VCF EGAD00001008577<\/td>\n<\/tr>\n<tr class=\"row-21\">\n\t<td class=\"column-1\">Dr David Twesigomwe<\/td><td class=\"column-2\">University of the Witwatersrand, South Africa<\/td><td class=\"column-3\">Characterisation of pharmacogene allelic variation in African populations and development of a novel diplotype calling algorithm: Phase 2<\/td><td class=\"column-4\">WGS and WES datasets: <br \/>\nH3AChip-Elsi EGAD00001004316<br \/>\nH3AChip-Malsic EGAD00001004557<br \/>\nH3AChip-Trypanogen 1 EGAD00001004393<br \/>\nH3AChip-Accme EGAD00001004505<br \/>\nH3AChip-Needi EGAD00001004334<br \/>\nCAfGEN Exome EGAD00001006224<br \/>\nH3AChip-Trypanogen 2 EGAD00001004220<br \/>\nH3AChip-Awi-gen EGAD00001004448<br \/>\nH3AChip-Cafgen EGAD00001004533<br \/>\nAWI-Gen Phase 1 WGS data from 100 South Africans EGAD00001006418<\/td>\n<\/tr>\n<tr class=\"row-22\">\n\t<td class=\"column-1\">Tabitha Osler<\/td><td class=\"column-2\">University of the Witwatersrand, South Africa<\/td><td class=\"column-3\">Prevalence and consequences of variants in genes associated with breast cancer in black South African women<\/td><td class=\"column-4\">WGS datasets:<br \/>\nTrypanoGEN Main EGAD00001005076<br \/>\nH3Africa Consortium WGS VCF EGAD00001008577<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-24 from cache -->[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text css=&#8221;.vc_custom_1631098962553{margin-top: 36px !important;}&#8221;] DBAC Approvals [\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-11423","page","type-page","status-publish","hentry","category-consortium-documents-consortium-documents"],"_links":{"self":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/pages\/11423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/comments?post=11423"}],"version-history":[{"count":3,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/pages\/11423\/revisions"}],"predecessor-version":[{"id":11429,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/pages\/11423\/revisions\/11429"}],"wp:attachment":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/media?parent=11423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/categories?post=11423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/tags?post=11423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}